Clinical Trial: Tofacitnib for the Treatment of Alopecia Areata and Variants

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Tofacitnib for the Treatment of Alopecia Areata and Variants

Brief Summary: The purpose of this study is to investigate the ability of tofacitinib citrate, a Janus kinase inhibitor, to generate hair regrowth in patients with moderate to severe alopecia areata and its variants.